InMed Pharmaceuticals Inc. (INM) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $13.43M | +45.9% |
| 2024 | $9.21M | -23.9% |
| 2023 | $12.09M | +33.2% |
| 2022 | $9.08M | +23.1% |
| 2021 | $7.38M | +25.5% |
| 2020 | $5.88M | -58.7% |
| 2019 | $14.24M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $13.43M | +45.9% |
| 2024 | $9.21M | -23.9% |
| 2023 | $12.09M | +33.2% |
| 2022 | $9.08M | +23.1% |
| 2021 | $7.38M | +25.5% |
| 2020 | $5.88M | -58.7% |
| 2019 | $14.24M | — |